Hi lazzaman, I’m in same boat somewhat with no experience in the pharmaceutical area but found some joy regarding patents and security processes in the research by Fiftyone Capital. PAR report is in the market insights area. Don’t know if it’s watertight.
Regards Tommy
FA bagger potential, page-48
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.005(1.96%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 25.0¢ | $3.008K | 12.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 26937 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 31814 | 6 |
View Market Depth
| Last trade - 10.06am 02/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |